AHCO — Adapthealth Income Statement
0.000.00%
Last trade - 00:00
- $1.32bn
- $3.43bn
- $3.20bn
- 65
- 78
- 79
- 86
R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K/A | 10-K/A | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 530 | 1,056 | 2,455 | 2,971 | 3,200 |
Cost of Revenue | |||||
Gross Profit | 101 | 180 | 515 | 501 | 570 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 502 | 990 | 2,249 | 2,791 | 3,828 |
Operating Profit | 27.3 | 66 | 205 | 179 | -628 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -21.9 | -206 | 191 | 97.9 | -724 |
Provision for Income Taxes | |||||
Net Income After Taxes | -22.6 | -194 | 158 | 73.1 | -675 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -21.3 | -162 | 156 | 69.3 | -679 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -21.3 | -162 | 142 | 63.4 | -679 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.318 | -2.82 | 1.5 | 0.652 | -0.767 |